In the spring of 2025, the Capital Region of Denmark and Region Zealand conducted a preliminary market assessment regarding LIMS for pathology with selected LIMS vendors, as preparation for a more targeted market dialogu…
e. The initial market assessment revealed that some aspects remain unclear for the regions regarding what the market is able to offer. This is especially the case for molecular pathology, where further insight is needed into which standard systems, currently available on the market, can meet the ide
ntified needs and how they do so—particularly how they support seamless digital integration with the pathology unit’s “classical pathology” workflow. The regions thus wish to gain greater insight into what the market can deliver and are the